Aequus Pharmaceuticals Inc

(AQSZF)

By |

Profile

Aequus Pharmaceuticals Inc is a Canada based specialty pharmaceutical company. The firm's operating segments are Commercial platform and Development pipeline. It generates a majority of its revenue from the Commercial platform segment. Aequus is developing a pipeline of products in neurology and psychiatry. The company's launched and pipeline products are Tacrolimus IR, Vistitan, AQS1304, AQS1303, and others.

Contact Information

Website: www.aequuspharma.ca
Main Phone: +1 604 336-7906
Address: 200 Granville Street
Address 2: Suite 2820
State: BC
City / Town: Vancouver
Country: CA
Postal Code: V6C 1S4

Issuer Information

Exchange: OTCQB
CEO: Douglas Glen Janzen
Employees: 10
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

Profile

Aequus Pharmaceuticals Inc is a Canada based specialty pharmaceutical company. The firm's operating segments are Commercial platform and Development pipeline. It generates a majority of its revenue from the Commercial platform segment. Aequus is developing a pipeline of products in neurology and psychiatry. The company's launched and pipeline products are Tacrolimus IR, Vistitan, AQS1304, AQS1303, and others.

Contact Information

Website: www.aequuspharma.ca
Main Phone: +1 604 336-7906
Address: 200 Granville Street
Address 2: Suite 2820
State: BC
City / Town: Vancouver
Country: CA
Postal Code: V6C 1S4

Issuer Information

Exchange: OTCQB
CEO: Douglas Glen Janzen
Employees: 10
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

$ 0.0837 $ -0.00705 (-7.77%)
Last Price 0.0837 Change $ -0.00705 Change % -7.77 Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open 0.0899 High 0.0899 Low 0.0837 Prev Close 0.09075
Last Trade Volume 7,964 52 Wk Hi 0.12 52 Wk Low 0.05
Market Cap 9.3 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 111,916,540.00 EPS (TTM) N/A PE Ratio N/A Exchange OTCQB